ARTICLE | Clinical News
MTC-DOX: Phase II
November 25, 2002 8:00 AM UTC
FeRx started a open-label Chinese Phase II repeat dosing study of MTC-DOX in 30 patients. ...
Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
FeRx started a open-label Chinese Phase II repeat dosing study of MTC-DOX in 30 patients. ...